Source: Eur Respir Rev 2012 21: 218-222
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dermot S. O'Callaghan, Marc Humbert. A critical analysis of survival in pulmonary arterial hypertension. Eur Respir Rev 2012 21: 218-222

Member's Comments

No comment yet.

Related content which might interest you: The study of risk in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:234-238 Year: 2012 Improving survival in pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 218-220 Year: 2005 Predicting survival in pulmonary arterial hypertension in the UK}, Source: Eur Respir J 2012; 40: 604-611 Year: 2012 Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012 Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH) Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 A USA-based registry for pulmonary arterial hypertension: 1982 2006 Source: Eur Respir J 2007; 30: 1103-1110 Year: 2007 Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 Mobile spiroergometry for prediction of survival in pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Pulmonary arterial hypertension in children Source: Eur Respir J 2003; 21: 155-176 Year: 2003 Association of renal dysfunction with hemodynamics and survival in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children Source: Eur Respir J 2011; 37: 70-77 Year: 2011 Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target Source: Eur Respir J 2011; 38: 1453-1460 Year: 2011 The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy Source: Eur Respir J 2001; 17: 653-659 Year: 2001 COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020 Year: 2020 Impact of initial treatment strategy on long-term survival in pulmonary arterial hypertension (PAH) Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003 Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012